Cannabis reduces prevalence, progression of steatohepatitis in obese patients

Cannabis use correlated with a decreased prevalence and progression of steatohepatitis among patients who were obese, according to results presented at the American College of Gastroenterology Virtual Annual Meeting.“These findings could possibly be explained by the anti-inflammatory and hepatoprotective effect of cannabis on hepatocytes through the endocannabinoid system,” Ikechukwu Achebe, MD, from John H. Stroger, Jr. Hospital of Cook County in Chicago, said during his presentation. “Additional studies are needed to further explore this relationship.”Achebe andRead More

Share on facebook
Share on twitter
Share on linkedin